Send mail to Author

Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
            ______    ____      ______   _    _      ___    
  ____     /_   _//  |  _ \\   /_   _// | || | ||   / _ \\  
 |    \\    -| ||-   | |_| ||   -| ||-  | || | ||  | / \ || 
 | [] ||    _| ||_   | .  //    _| ||_  | \\_/ ||  | \_/ || 
 |  __//   /_____//  |_|\_\\   /_____//  \____//    \___//  
 |_|`-`    `-----`   `-` --`   `-----`    `---`     `---`   
 `-`                                                        
 


Back to frontdoor view